Home Stocks Drug Trial Failure Continues to Sting Kamada on Wall Street

Drug Trial Failure Continues to Sting Kamada on Wall Street

When you purchase through our sponsored links, we may earn a commission. By using this website you agree to our T&Cs.

Demandware Inc (NYSE:DWRE), Senomyx Inc. (NASDAQ:SNMX) and Gogo Inc (NASDAQ:GOGO) are starting off the week strong and are today’s top gainers midday. The losers are dELiA*s, Inc. (NASDAQ:DLIA), QuickLogic Corporation (NASDAQ:QUIK) and Kamada Ltd (NASDAQ:KMDA).

Soros Picks Senomyx, Gogo Soar

Demandware Inc (NYSE:DWRE) is today’s top gainer, its price surging +10.94%. A Julian Robertson holding, the e-commerce solutions provider is up +5.19% since reporting results on May 6th.

Following Demandware on this Monday’s list of midday gainers is Senomyx Inc. (NASDAQ:SNMX), up +10.38%. The company announced the two-year extension of an agreement with Pepsi – likely the reason for the price surge of this George Soros pick.

Last up is Gogo Inc (NASDAQ:GOGO), which got a +9.28% boost on the stock market today. UBS upgraded its rating of the in-flight telecommunications provider from neutral to buy and also set its target price at $26. Soros added Gogo to his portfolio in Q1.

Kamada Falls

dELiA*s, Inc. (NASDAQ:DLIA) slipped -8.88% midday today. The retailer has been in the Tiger Global portfolio for two quarters.

The share price of QuickLogic Corporation (NASDAQ:QUIK) -6.81% by midday, despite having started off strong this morning. George Soros initiated a position in QUIK during the first quarter of 2014.

Also on the losing end of the market this Monday is Kamada Ltd (NASDAQ:KMDA), down -6.50%. The Israeli drugmaker announced that one of its products had failed a key trial last week, and its stock continues to suffer the fall-out. Billionaire John Paulson has a position in the company.

Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

iBillionaire
Editor

Want Financial Guidance Sent Straight to You?

  • Pop your email in the box, and you'll receive bi-weekly emails from ValueWalk.
  • We never send spam — only the latest financial news and guides to help you take charge of your financial future.